Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Flora, Sanzida Alam
Άλλοι συγγραφείς:	Azam, Faruque
Μορφή:	Thesis
Γλώσσα:	English
Έκδοση:	Brac University 2024
Θέματα:	NSCLC Tyrosine kinase inhibitor Efficacy endpoints Cancer therapy Lung cancer Lung cancer > Treatment Protein-tyrosine kinase > Inhibitors > Therapeutic use
Διαθέσιμο Online:	http://hdl.handle.net/10361/23693

Παρόμοια τεκμήρια

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
ανά: Khan, Muidul Hasan
Έκδοση: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
ανά: Paul, Pulock
Έκδοση: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
ανά: Rahman, Tasnim
Έκδοση: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
ανά: Sorno, Rubina Haque
Έκδοση: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
ανά: Hoque, Ismoth Ara
Έκδοση: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
ανά: Karim, Samia Binte
Έκδοση: (2024)

Immunotherapy in the Management of Lung Cancer
ανά: Tasnim, Humayra
Έκδοση: (2022)

Molecules associated with the development of lung cancer
ανά: Rahman, Adree, κ.ά.
Έκδοση: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
ανά: Jeba, Joynob
Έκδοση: (2017)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
ανά: Meem, Manila
Έκδοση: (2023)

A review on targeted therapies for lung cancer
ανά: Ashraf, Anushey
Έκδοση: (2023)

Potential of liposomes for the treatment of lung cancer- a review
ανά: Mim, Shanzida
Έκδοση: (2023)

A review on recent advances in drugs for lung cancer treatment
ανά: Noor, Fouzia
Έκδοση: (2024)

A review on potential of PARP inhibitors in the treatment of prostate cancer
ανά: Islam, Saidul
Έκδοση: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
ανά: Das, Reshita
Έκδοση: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
ανά: Pial, Sazia Afrin
Έκδοση: (2018)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
ανά: Razna, Amrin Islam
Έκδοση: (2019)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
ανά: Shobnam, Sohana
Έκδοση: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
ανά: Shabnam, Musharrat
Έκδοση: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
ανά: Zangmo, Thinley
Έκδοση: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
ανά: Tania, Umme
Έκδοση: (2023)

In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
ανά: Ruhee, Noshin Nawer
Έκδοση: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
ανά: Jahan, Nusrat
Έκδοση: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
ανά: Bristy, Israt Zerin
Έκδοση: (2021)

Lung cancer detection and classification using machine learning
ανά: Arefin, Mahbubul, κ.ά.
Έκδοση: (2023)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
ανά: Karim, Azrin
Έκδοση: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
ανά: Haque, Mushfiqul
Έκδοση: (2019)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
ανά: Mukti, Roushney Fatima, κ.ά.
Έκδοση: (2016)

A review on insulin-producing beta cell: regenerative role of drugs acting on DYRK1A, GLP-1 and DPP-4 receptors
ανά: Mahmood, Nyrit
Έκδοση: (2021)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
ανά: Ratu, Tabassum
Έκδοση: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
ανά: Mirza, Maisa Tasnim
Έκδοση: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
ανά: Nandy, Aditi
Έκδοση: (2022)

Statistics and informatics in molecular cancer research

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
ανά: Hasan, Amit
Έκδοση: (2024)

Identification of FAP inhibitors using in silico simulation study
ανά: Deeba, Maliha Tasnim
Έκδοση: (2018)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
ανά: Abir, Shifaty Nur
Έκδοση: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
ανά: Hossain, Safa Binte
Έκδοση: (2019)

Recent advances in Cancer treatment targeting autophagy and future aspects
ανά: Emon, Kamrul Hasan
Έκδοση: (2022)

Cancer risk factors: a critical review
ανά: Tabassum, Tahsina
Έκδοση: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
ανά: Nawar, Anika
Έκδοση: (2019)